Corteva (NYSE:CTVA) Price Target Raised to $74.00 at BNP Paribas Exane

Corteva (NYSE:CTVA) had its price objective lifted by BNP Paribas Exane from $72.00 to $74.00 in a research report sent to investors on Monday,MarketScreener reports.

CTVA has been the topic of several other research reports. Royal Bank Of Canada boosted their price target on Corteva from $80.00 to $89.00 and gave the company an “outperform” rating in a research note on Thursday, February 5th. Weiss Ratings reissued a “hold (c-)” rating on shares of Corteva in a report on Monday, December 29th. Oppenheimer set a $86.00 target price on shares of Corteva in a research note on Thursday, February 5th. Mizuho upped their target price on shares of Corteva from $80.00 to $82.00 and gave the stock an “outperform” rating in a report on Tuesday, February 17th. Finally, Deutsche Bank Aktiengesellschaft increased their target price on shares of Corteva from $85.00 to $90.00 and gave the stock a “buy” rating in a research report on Thursday, February 5th. One equities research analyst has rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and eight have assigned a Hold rating to the stock. According to data from MarketBeat, Corteva has a consensus rating of “Moderate Buy” and an average price target of $82.90.

Corteva Stock Performance

NYSE CTVA opened at $78.36 on Monday. Corteva has a twelve month low of $53.40 and a twelve month high of $80.90. The company has a quick ratio of 0.96, a current ratio of 1.43 and a debt-to-equity ratio of 0.07. The stock has a market cap of $52.70 billion, a P/E ratio of 49.59, a PEG ratio of 2.63 and a beta of 0.72. The company’s 50-day simple moving average is $73.22 and its 200 day simple moving average is $69.04.

Corteva (NYSE:CTVA) last announced its quarterly earnings results on Tuesday, February 3rd. The company reported $0.22 EPS for the quarter, hitting analysts’ consensus estimates of $0.22. Corteva had a net margin of 6.29% and a return on equity of 9.06%. The firm had revenue of $3.91 billion during the quarter, compared to analysts’ expectations of $4.23 billion. During the same quarter last year, the company earned $0.32 earnings per share. The company’s revenue for the quarter was down 1.7% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. As a group, research analysts forecast that Corteva will post 2.96 earnings per share for the current fiscal year.

Corteva Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, March 16th. Shareholders of record on Monday, March 2nd will be issued a dividend of $0.18 per share. The ex-dividend date of this dividend is Monday, March 2nd. This represents a $0.72 dividend on an annualized basis and a yield of 0.9%. Corteva’s dividend payout ratio is currently 45.57%.

Insiders Place Their Bets

In other Corteva news, insider Brian Titus sold 8,311 shares of the business’s stock in a transaction dated Friday, February 20th. The shares were sold at an average price of $76.55, for a total value of $636,207.05. Following the completion of the transaction, the insider directly owned 8,090 shares of the company’s stock, valued at approximately $619,289.50. The trade was a 50.67% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Insiders own 0.15% of the company’s stock.

Institutional Trading of Corteva

Several hedge funds have recently modified their holdings of CTVA. Corient Private Wealth LLC increased its holdings in shares of Corteva by 3.5% in the fourth quarter. Corient Private Wealth LLC now owns 201,416 shares of the company’s stock valued at $13,505,000 after purchasing an additional 6,854 shares in the last quarter. Storen Legacy Partners LLC acquired a new position in Corteva during the 4th quarter worth $404,000. SHP Wealth Management bought a new position in Corteva in the 4th quarter valued at $165,000. Reflection Asset Management bought a new position in Corteva in the 4th quarter valued at $44,000. Finally, MidFirst Bank acquired a new stake in shares of Corteva in the 4th quarter valued at $1,282,000. 81.54% of the stock is owned by institutional investors.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.